NGL FINE CHEM LIMITED (NGLFINE) financials

NGL FINE CHEM LIMITED (NGLFINE) NSE/BSE financials on Fincrux: quarterly results, profit and loss, cash flow, balance sheet, ratios, and shareholding.

Incorporated in 1981, NGL Fine-Chem Ltd is a manufacturer and exporter of pharmaceuticals and intermediates for usage in veterinary and human health.[1]

Market Cap: ₹1,677Cr.
Current Price: ₹2,714
Stock P/E: 33.2
ROE: 15.6%
ROCE: 16.7%
Book Value: ₹518
Dividend Yield: 0.07%
52W High / Low: ₹3,602/1,261

In Jun 2026, NGL FINE CHEM LIMITED (NGLFINE) reported sales ₹137 Cr and net profit ₹16 Cr.

Annual TTM: sales ₹525 Cr, net profit ₹50 Cr.

Shareholding: Promoters 72.49% (Sep 2026), FIIs 0.04% (Sep 2026), DIIs 0.00% (Sep 2026), Public 27.46% (Sep 2026), No. of Shareholders 12,939% (Sep 2026).

NGLFINE quarterly results (₹ Cr.)
Category	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Sales	91	87	93	101	117	126	145	137
Expenses	81	83	89	93	103	106	127	117
Operating Profit	11	4	4	8	14	20	18	20
OPM %	12%	4.1%	4.2%	8%	12%	16%	12%	14%
Other Income	5	0	-1	7	2	5	3	7
Interest	0	1	1	1	1	1	1	1
Depreciation	2	2	3	3	4	4	4	4
Profit before tax	13	1	-0	10	11	19	15	22
Tax %	25%	4%	44%	21%	26%	24%	24%	24%
Net Profit	10	1	-1	8	8	15	11	16
EPS in Rs	16.25	1.26	-0.84	12.37	12.79	23.86	18.37	26.63
Raw PDF	—	—	—	—	—	—	—	—

NGLFINE profit and loss (₹ Cr.)
Category	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026	TTM
Sales	152	258	319	275	329	359	489	525
Expenses	129	181	253	246	284	332	421	454
Operating Profit	23	77	66	29	45	27	68	71
OPM %	15%	30%	21%	10%	14%	7%	14%	14%
Other Income	1	9	13	8	16	10	8	17
Interest	3	2	2	2	2	3	5	4
Depreciation	7	7	8	8	8	9	16	17
Profit before tax	14	76	69	27	51	24	55	67
Tax %	26%	27%	24%	24%	24%	24%	24%	—
Net Profit	11	55	52	20	39	18	42	50
EPS in Rs	17.16	89.79	84.57	32.57	62.35	29.35	67.38	81.65
Dividend Payout %	10%	2%	2%	5%	3%	6%	3%	—

NGLFINE balance sheet (₹ Cr.)
Category	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Equity Capital	3	3	3	3	3	3	3	3
Reserves	89	98	152	203	222	260	277	317
Borrowings	27	28	16	30	32	34	77	122
Other Liabilities	23	26	34	41	30	56	70	88
Total Liabilities	142	156	206	278	288	353	426	530
Fixed Assets	61	61	58	59	59	60	120	144
CWIP	0	0	1	6	26	46	50	95
Investments	9	14	33	32	43	57	63	43
Other Assets	73	80	115	180	159	190	193	248
Total Assets	142	156	206	278	288	353	426	530

NGLFINE cash flows (₹ Cr.)
Category	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Cash from Operating Activity	9	20	27	13	32	11	22	35
Cash from Investing Activity	-10	-19	-24	-13	-24	-17	-58	-65
Cash from Financing Activity	0	-1	-1	-1	-1	-1	36	30
Net Cash Flow	-1	-0	2	-1	7	-7	0	0
Free Cash Flow	-6	12	22	-2	3	-17	-51	-51
CFO/EBITDA Share of operating profit converting into cash: CFO (before tax) / Operating Profit	50%	101%	61%	45%	134%	52%	104%	70%

NGLFINE shareholding pattern (%)
Category	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026	Sep 2026
Promoters	72.74%	72.74%	72.74%	72.74%	72.74%	72.73%	72.49%	72.49%
FIIs	0.05%	0.00%	0.00%	0.00%	0.00%	0.03%	0.05%	0.04%
DIIs	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.02%	0.00%
Public	27.23%	27.26%	27.26%	27.26%	27.26%	27.23%	27.43%	27.46%
No. of Shareholders	14,110	14,386	14,010	13,387	12,834	12,516	13,393	12,939

NGLFINE key ratios
Category	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Debtor Days	79	63	53	74	86	92	81	94
Inventory Days	106	154	132	133	69	99	95	101
Days Payable	92	114	94	84	59	110	94	89
Cash Conversion Cycle	93	103	91	124	97	82	83	106
Working Capital Days	70	63	71	89	67	71	51	59
ROCE %	28%	15%	52%	35%	12%	19%	8%	17%

NGLFINEUpdated 22 Oct 2026, 11:00

Ngl Fine Chem Limited

NGLFINEUpdated 22 Oct 2026, 11:00

Market Cap

₹1,677Cr.

Current Price

₹2,714

High / Low

₹3,602/1,261

Stock P/E

33.2

Book Value₹518

Dividend Yield0.07%

ROCE16.7%

ROE15.6%

Face Value₹5.00

About

Incorporated in 1981, NGL Fine-Chem Ltd is a manufacturer and exporter of pharmaceuticals and intermediates for usage in veterinary and human health.[1]

Quarterly results

Last reported quarters₹ Cr.

Quarter	Sales	Interest	Expenses	Other Income	Depreciation	Profit Before Tax	Tax	Net Profit	EPS (₹)
Jun 2023	69	0	62	4	2	9	15	8	12.64
Sep 2023	79	0	66	4	2	15	24	11	17.76
Dec 2023	85	0	74	4	2	13	30	9	14.41
Mar 2024	96	0	83	4	2	14	24	11	17.56
Jun 2024	88	0	82	6	2	10	22	8	12.67
Sep 2024	91	0	81	5	2	13	25	10	16.25
Dec 2024	87	1	83	0	2	1	4	1	1.26
Mar 2025	93	1	89	-1	3	0	44	-1	-0.84
Jun 2025	101	1	93	7	3	10	21	8	12.37
Sep 2025	117	1	103	2	4	11	26	8	12.79
Dec 2025	126	1	106	5	4	19	24	15	23.86
Mar 2026	145	1	127	3	4	15	24	11	18.37
Jun 2026	137	1	117	7	4	22	24	16	26.63

Profit & loss

Annual statement₹ Cr.

Year	Sales	Interest	Expenses	Other Income	Depreciation	Profit Before Tax	Tax	Net Profit	EPS (₹)
Mar 2015	88	2	73	2	3	13	35	8	13.48
Mar 2016	96	2	74	0	3	18	36	11	18.45
Mar 2017	100	1	74	1	3	23	35	15	24.1
Mar 2018	114	2	92	3	5	18	29	13	20.38
Mar 2019	153	3	121	4	6	28	27	20	32.58
Mar 2020	152	3	129	1	7	14	26	11	17.16
Mar 2021	258	2	181	9	7	76	27	55	89.79
Mar 2022	319	2	253	13	8	69	24	52	84.57
Mar 2023	275	2	246	8	8	27	24	20	32.57
Mar 2024	329	2	284	16	8	51	24	39	62.35
Mar 2025	359	3	332	10	9	24	24	18	29.35
Mar 2026	489	5	421	8	16	55	24	42	67.38
TTM	525	4	454	17	17	67	—	50	81.65

Shareholding pattern

As of Sep 2026%

Holder	Share
Promoters	72.49%
FIIs	0.04%
Public	27.46%

Shareholding trend

Ownership over time%

Quarter	Promoters	FIIs	DIIs	Public
Dec 2023	73.06%	0.04%	0%	26.91%
Mar 2024	72.74%	0.1%	0%	27.16%
Jun 2024	72.74%	0.03%	0%	27.24%
Sep 2024	72.74%	0.02%	0%	27.25%
Dec 2024	72.74%	0.05%	0%	27.23%
Mar 2025	72.74%	0%	0%	27.26%
Jun 2025	72.74%	0%	0%	27.26%
Sep 2025	72.74%	0%	0%	27.26%
Dec 2025	72.74%	0%	0%	27.26%
Mar 2026	72.73%	0.03%	0%	27.23%
Jun 2026	72.49%	0.05%	0.02%	27.43%
Sep 2026	72.49%	0.04%	0%	27.46%

Balance sheet

Assets & liabilities₹ Cr.

Period	Equity Capital	Reserves	Borrowings	Other Liabilities	Total Liabilities	Fixed Assets	CWIP	Investments	Other Assets	Total Assets
Mar 2015	3	30	13	21	67	17	1	2	46	67
Mar 2016	3	41	14	19	78	24	2	3	49	78
Mar 2017	3	56	23	20	102	25	16	6	55	102
Mar 2018	3	69	27	31	129	56	3	6	63	129
Mar 2019	3	89	27	23	142	61	0	9	73	142
Mar 2020	3	98	28	26	156	61	0	14	80	156
Mar 2021	3	152	16	34	206	58	1	33	115	206
Mar 2022	3	203	30	41	278	59	6	32	180	278
Mar 2023	3	222	32	30	288	59	26	43	159	288
Mar 2024	3	260	34	56	353	60	46	57	190	353
Mar 2025	3	277	77	70	426	120	50	63	193	426
Mar 2026	3	317	122	88	530	144	95	43	248	530

Cash flows

Operating, investing & financing₹ Cr.

Period	Operating	Investing	Financing	Net cash flow
Mar 2015	8	-3	-4	1
Mar 2016	8	-10	2	0
Mar 2017	10	-10	0	0
Mar 2018	22	-21	0	1
Mar 2019	9	-10	0	-1
Mar 2020	20	-19	-1	0
Mar 2021	27	-24	-1	2
Mar 2022	13	-13	-1	-1
Mar 2023	32	-24	-1	7
Mar 2024	11	-17	-1	-7
Mar 2025	22	-58	36	0
Mar 2026	35	-65	30	0

Key ratios

Historical financial ratios

Category	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Debtor Days	107	123	110	89	79	63	53	74	86	92	81	94
Inventory Days	106	90	114	134	106	154	132	133	69	99	95	101
Days Payable	150	122	139	187	92	114	94	84	59	110	94	89
Cash Conversion Cycle	63	91	85	35	93	103	91	124	97	82	83	106
Working Capital Days	38	49	45	18	70	63	71	89	67	71	51	59
ROCE %	29%	37%	34%	22%	28%	15%	52%	35%	12%	19%	8%	17%

Frequently asked questions

Quick answers about this company's financials on Fincrux

What is the market cap of NGL FINE CHEM LIMITED (NGLFINE)?

The reported market capitalisation for NGL FINE CHEM LIMITED (NGLFINE) is ₹1,677Cr. on Fincrux. Figures may update with market data and filings.

What is the current share price of NGLFINE?

The current price shown for NGL FINE CHEM LIMITED (NGLFINE) on Fincrux is ₹2,714 with a 52-week high/low of ₹3,602/1,261.

What is the P/E ratio of NGL FINE CHEM LIMITED (NGLFINE)?

The stock P/E for NGL FINE CHEM LIMITED (NGLFINE) is 33.2 on Fincrux, with ROE at 15.6% and ROCE at 16.7%.

What were NGLFINE latest quarterly results?

For Jun 2026, NGL FINE CHEM LIMITED (NGLFINE) reported sales ₹137 Cr and net profit ₹16 Cr (figures in ₹ crore unless noted).

What are NGLFINE annual sales and net profit?

For TTM, NGL FINE CHEM LIMITED (NGLFINE) shows sales of ₹525 Cr and net profit of ₹50 Cr on the Fincrux profit & loss statement.

Who owns NGL FINE CHEM LIMITED (NGLFINE)?

Latest shareholding for NGL FINE CHEM LIMITED (NGLFINE) on Fincrux: Promoters 72.49% (Sep 2026), FIIs 0.04% (Sep 2026), DIIs 0.00% (Sep 2026), Public 27.46% (Sep 2026), No. of Shareholders 12,939% (Sep 2026).

Where can I find NGL FINE CHEM LIMITED (NGLFINE) financials?

NGL FINE CHEM LIMITED (NGLFINE) financials on Fincrux include quarterly results, profit and loss, cash flow, balance sheet, key ratios, and shareholding patterns for NSE/BSE research.

Does Fincrux show NGLFINE balance sheet and cash flow?

Yes. The NGL FINE CHEM LIMITED (NGLFINE) page on Fincrux includes balance sheet, cash flow statements, historical ratios, and ownership trends alongside quarterly and annual results.

Figures in ₹ crore unless noted. Data sourced for research and may lag filings.

Last updated 22 October 2026 at 11:00